DEGLI UBERTI, Ettore
 Distribuzione geografica
Continente #
NA - Nord America 35.276
AS - Asia 18.813
EU - Europa 16.957
SA - Sud America 2.935
AF - Africa 398
Continente sconosciuto - Info sul continente non disponibili 332
OC - Oceania 31
Totale 74.742
Nazione #
US - Stati Uniti d'America 34.424
SG - Singapore 6.974
FI - Finlandia 6.374
CN - Cina 4.971
DE - Germania 3.130
BR - Brasile 2.315
UA - Ucraina 2.017
VN - Vietnam 1.927
IT - Italia 1.563
HK - Hong Kong 1.495
TR - Turchia 1.239
GB - Regno Unito 1.043
RU - Federazione Russa 760
FR - Francia 623
SE - Svezia 586
BD - Bangladesh 544
JP - Giappone 426
CA - Canada 395
IN - India 362
MX - Messico 294
PL - Polonia 277
AR - Argentina 216
ZA - Sudafrica 163
ID - Indonesia 122
IQ - Iraq 118
PK - Pakistan 108
ES - Italia 105
NL - Olanda 101
EC - Ecuador 99
CO - Colombia 82
BE - Belgio 78
VE - Venezuela 74
UZ - Uzbekistan 63
MA - Marocco 54
SA - Arabia Saudita 53
MY - Malesia 52
CL - Cile 51
PH - Filippine 51
LT - Lituania 46
AT - Austria 38
TN - Tunisia 37
AE - Emirati Arabi Uniti 34
PY - Paraguay 33
JM - Giamaica 31
KE - Kenya 31
AU - Australia 27
IR - Iran 27
PE - Perù 26
DZ - Algeria 25
IE - Irlanda 25
JO - Giordania 24
NP - Nepal 24
AL - Albania 22
EG - Egitto 21
CR - Costa Rica 20
UY - Uruguay 20
PS - Palestinian Territory 19
TT - Trinidad e Tobago 19
AZ - Azerbaigian 18
CH - Svizzera 18
LB - Libano 18
RO - Romania 18
CZ - Repubblica Ceca 17
DK - Danimarca 16
DO - Repubblica Dominicana 16
HN - Honduras 16
KZ - Kazakistan 16
BO - Bolivia 15
IL - Israele 15
EU - Europa 14
OM - Oman 14
TH - Thailandia 13
ET - Etiopia 12
GR - Grecia 12
PT - Portogallo 12
GT - Guatemala 11
KR - Corea 11
LV - Lettonia 10
MD - Moldavia 10
PA - Panama 10
SV - El Salvador 10
BG - Bulgaria 9
GA - Gabon 9
KG - Kirghizistan 9
RS - Serbia 9
BB - Barbados 8
CY - Cipro 8
QA - Qatar 8
BH - Bahrain 7
GE - Georgia 7
HU - Ungheria 7
PR - Porto Rico 7
AM - Armenia 6
NG - Nigeria 6
SK - Slovacchia (Repubblica Slovacca) 6
SY - Repubblica araba siriana 6
AO - Angola 5
HR - Croazia 5
KW - Kuwait 5
MT - Malta 5
Totale 74.332
Città #
Helsinki 5.836
Singapore 4.552
Ashburn 3.922
Woodbridge 3.027
Fairfield 2.449
San Jose 2.354
Jacksonville 2.171
Chandler 2.078
Houston 1.778
Beijing 1.547
Santa Clara 1.529
Hong Kong 1.476
Ann Arbor 1.271
Seattle 978
Wilmington 952
Cambridge 747
Izmir 680
Ho Chi Minh City 651
Nanjing 620
Los Angeles 608
New York 550
Dallas 505
Hanoi 445
Princeton 441
Tokyo 414
Munich 399
Addison 384
Council Bluffs 383
Lauterbourg 358
Milan 301
San Diego 281
Boardman 269
Warsaw 262
São Paulo 256
Shanghai 212
Shenyang 198
Mexico City 197
Orem 183
Nanchang 181
Dearborn 163
Ferrara 138
Turku 137
Buffalo 135
Hebei 134
Tianjin 133
Hefei 128
Montreal 125
Washington 123
London 121
Changsha 117
Chicago 115
Denver 114
Bremen 110
Toronto 110
Brooklyn 105
Jiaxing 97
Chennai 96
San Francisco 96
Johannesburg 93
Phoenix 93
Jinan 84
Haiphong 83
Da Nang 82
Boston 79
Atlanta 78
Rome 76
Frankfurt am Main 70
Falls Church 69
Brussels 68
Moscow 68
Mountain View 67
Stockholm 67
Manchester 64
Poplar 64
Rio de Janeiro 63
San Mateo 63
Belo Horizonte 60
Baghdad 54
The Dalles 54
Guangzhou 53
Tashkent 53
Norwalk 52
Hải Dương 51
Kunming 49
Zhengzhou 48
Falkenstein 45
Ningbo 45
Redwood City 45
Amsterdam 44
Philadelphia 44
Ankara 40
Biên Hòa 40
Carrara 40
Nuremberg 39
Charlotte 38
Lahore 38
Quito 38
Brasília 37
Jakarta 37
Auburn Hills 36
Totale 50.153
Nome #
Metodo per modulare la proliferazione del carcinoma midollare della tiroide (MTC) 1.988
Composti farmaceutici che inibiscono la proliferazione di adenomi ipofisari e modi d’uso che ne derivano 1.961
Uso di inibitori delle Cicloossigenasi di tipo 2 come agenti atti a modificare la farmacoresistenza cellulare 1.959
SRC homology-2-containing protein tyrosine phosphatase-1 restrains cell proliferation in human medullary thyroid carcinoma 436
Dermorphin inhibits spinal nociceptive flexion reflex in humans 410
Control of pituitary adenoma cell proliferation by somatostatin analogs, dopamine agonists and novel chimeric compounds 330
Stimulatory effect of dermorphin, a new synthetic potent opiate-like peptide, on human growth hormone secretion 300
Prolactin-Releasing Activity of Dermorphin, a New Synthetic Potent Opiate-Like Peptide, in Normal Human Subjects 292
HypoparaNet: A Database of Chronic Hypoparathyroidism Based on Expert Medical-Surgical Centers in Italy 291
Effect of Everolimus on Cell Viability in Nonfunctioning Pituitary Adenomas 289
Evaluation of the Role of BRAFV600E Somatic Mutation on Papillary Thyroid Cancer Disease Persistence: A Prospective Study 287
The effects of dermorphin on the endocrine system in man 284
Proposal for a novel management of indeterminate thyroid nodules on the basis of cytopathological subclasses 282
Role of Ultrasonographic/Clinical Profile, Cytology, and BRAF V600E Mutation Evaluation in Thyroid Nodule Screening for Malignancy: A Prospective Study 281
ROLL technique application for Minimally-Invasive Radioguided Parathyroidectomy (MIRP) in Hyperparathyroidism (HPT) 278
Cyclooxygenase-2 inhibitors prevent the development of chemoresistance phenotype in a breast cancer cell line by inhibiting glycoprotein p-170 expression 270
A novel germline CDKN1B mutation causing multiple endocrine tumors: clinical, genetic and functional characterization 270
Evaluation of ''ROLL-like'' procedure for minimallyinvasive radioguided parathyroidectomy (MIRP) in hyperparathyroidism (HPT). 264
Igf-I influences everolimus activity in medullary thyroid carcinoma 263
Relevance of BRAF(V600E) Mutation Testing Versus RAS Point Mutations and RET/PTC Rearrangements Evaluation in the Diagnosis of Thyroid Cancer 261
Characterization of a deleted Y chromosome in a male with Turner stigmata 260
Cyclooxygenase-2 inhibitors reverse chemoresistance phenotype in medullary thyroid carcinoma by a permeability glycoprotein-mediated mechanism 259
An in vivo OctreoScan-negative adrenal pheochromocytoma expresses somatostatin receptors and responds to somatostatin analogs treatment in vitro 259
Cholinergic mediation in dermorphin-induced growth hormone secretion in man 259
Cyclin D1 levels are involved in the resistance to m-TOR inhibitors in human bronchial carcinoids 256
Proteasomes and RARS modulate AIMP1/EMAP II secretion in human cancer cell lines 251
Everolimus as a new potential antiproliferative agent in aggressive human bronchial carcinoids 250
Circadian profile of plasma calcitonin gene-related peptide in healthy man 249
A practical method for the estimation of therapeutic activity in the treatment of Graves' hyperthyroidism 248
Selective activation of somatostatin receptor subtypes differentially modulates secretion and viability in human medullary thyroid carcinoma primary cultures: potential clinical perspectives. 247
Increase in Peripheral CD3-CD56brightCD16- Natural Killer Cells in Hashimoto's Thyroiditis Associated with HHV-6 Infection 245
Recettori della somatostatina e carcinoma midollare della tiroide: prospettive future. 245
BRAF V600E mutation analysis increases diagnostic accuracy for papillary thyroid carcinoma in fine-needle aspiration biopsies 244
Dermorphin, a new opioid peptide, stimulates thyrotropin secretion in normal subjects 243
Is there a correlation between BRAFV600 mutation, sentinel lymph node biopsy, pathological and clinical parameters in papillary thyroid carcinoma? 242
A c-myc gene variant without exon 1 and with an abnormal methylation pattern inherited in a woman with no evidence of malignancy 241
Predictors of Pituitary Dysfunction in Patients Surviving Ischemic Stroke 239
Inhibition of epithelial growth factor receptor can play an important role in reducing cell growth and survival in adrenocortical tumors 237
Effects of two mTOR inhibitors on in-vitro models of GH-secreting pituitary adenomas 235
Acute lowering of plasma GH concentrations by somatostatin is associated with activation of pituitary-adrenal-axisin healthy young and elderly subjects 235
Magmas Overexpression Inhibits Staurosporine Induced Apoptosis in Rat Pituitary Adenoma Cell Lines 234
Allelic discrimination in the diagnosis of somatic BRAF V600E mutation on fine-needle aspiration biopsies 233
Early onset acromegaly associated with a novel deletion in CDKN1B 5'UTR region 233
Functional characterization of a new deletion in CDKN1B 5'-UTR region 232
Activation of the somatotropic axis by testosterone in adult men: evidence for a role of hypothalamic growth hormone (GH)- releasing hormone function 231
The cytotoxic effect of sunitinib on human bronchial carcinoid cell lines and primary cultures is counteracted by EGF and IGF-1 but not by VEGF 231
Acute administration of human galanin in normal subjects reduces the potentiating effect of pyridostigmine-induced cholinergic enhancement on release of norepinephrine and pancreatic polypeptide 229
Protein Kinase C Delta restrains growth in ACTH-secreting pituitary adenoma cells 229
Presenza di HHV-6 in campioni tiroidei di pazienti con malattie autoimmuni della tiroide 228
RET mutation profile and variable clinical manifestations in a family with multiple endocrine neoplasia type 2A and Hirschsprung's disease 228
c-myc oncogene alterations in human thyroid carcinomas. 227
mTOR, AKT, p70S6K and ERK1/2 levels predict sensitivity to mTOR and PI3K/mTOR inhibitors in human bronchial carcinoids 226
Evaluation of hormonal function in a series of incidentally discovered adrenal masses 224
Virologic and immunologic evidence supporting an association between HHV-6 and Hashimoto’s thyroiditis 224
Different levels of thyroglobulin mRNA in normal and neoplastic human thyroids 223
Magmas, a Novel Over-Expressed Gene in Pituitary Rat Cell Lines and in Human Pituitary Adenomas: A New Pituitary Biomarker? 223
Consistent changes in the circadian rhythms of blood pressure and atrial natriuretic peptide in congestive heart failure 222
Radio-guided selective compartment neck dissection improves staging in papillary thyroid carcinoma: a prospective study on 345 patients with a 3-year follow-up. 222
Growth hormone receptor blockade inhibits growth hormone-induced chemoresistance by restoring cytotoxic-induced apoptosis in breast cancer cells independently of estrogen receptor expression 221
Circadian rhythm of calcitonin gene-related peptide in uncomplicated essential hypertension 220
Pasireotide, a multiple somatostatin receptor subtypes ligand, reduces cell viability in non-functioning pituitary adenomas by inhibiting vascular endothelial growth factor secretion 220
Cabergoline reduces cell viability in non functioning pituitary adenomas by inhibiting Vascular Endothelial Growth Factor secretion 218
BRAFV600E analysis on fine needle aspiration biopsy increases diagnostic accuracy for papillary thyroid cancer in clinically unsuspected nodules 217
Growth hormone excess promotes breast cancer chemoresistance 217
Growth hormone induces chemoresistance in breast cancer cells 217
Identification of differentially expressed microRNAs by microarray: A possible role for microRNA genes in pituitary adenomas 217
Epidermal growth factor pathway as a possible target in the medical therapy of bronchial carcinoids 217
Effect of deltorphin on pituitary-adrenal response to insulin-induced hypoglycemia and ovine corticotropin-releasing hormone in healthy man 216
Evidence for androgen receptor gene expression in human thyroid cells and tumours 216
Involvement of PKCβ and PKCδ isoforms in TSH signaling pathway in thyroid cancer cell lines 215
Cushing in a Leaf: Endocrine Disruption From a Natural Remedy 215
N-carbamidoyl-4-((3-ethyl-2,4,4-trimethylcyclohexyl)methyl)benzamide enhances staurosporine cytotoxic effects likely inhibiting the protective action of Magmas toward cell apoptosis 215
Differential mTOR and PI3K Pathway Activation in Human Bronchial Carcinoids 212
Circadian variations of plasma TSH in patients with severe hypothyroidism 210
Antiproliferative effects of somatostatin analogs in pituitary adenomas 208
Efficacy and safety of the new 60 mg formulation of the long acting somatostatin analog lanreotide in the treatment of acromegaly. 208
Effect of ketanserin, an inhibitor of 5-HT2 receptors, on the aldosterone-stimulating action of metoclopramide 207
Therapeutic concentrations of mitotane (o,p′-DDD) inhibit thyrotroph cell viability and TSH expression and secretion in a mouse cell line model 206
ADRENAL INCIDENTALOMA: CLINICAL AND METABOLIC ASPECTS DURING LONG-TERM FOLLOW-UP 206
miR-15a and miR-16-1 down-regulation in pituitary adenomas 206
Prolactin and growth hormone responses to dermorphin in patients with prolactin-secreting pituitary adenoma 206
Magmas, a Gene Newly Identified as Overexpressed in Human and Mouse ACTH-Secreting Pituitary Adenomas, Protects Pituitary Cells from Apoptotic Stimuli 205
Should aip gene screening be recommended in family members of FIPA patients with R16H variant? 205
IGF-I Proliferative Effects Are Inhibited by Targeting PKC in Human Endocrine Tumor Cells 204
Deletion of exons 1-3 of the MEN1 gene in a large Italian family causes the loss of menin expression 204
R171Q MEN1 polymorphism in patients presenting with hyperparathyroidism 204
A defective hypothalamic GHRH activity may contribute to declining GH secretion wuth age in man 203
An unusual association of hyperparathyroidism, ectopic GHRH secrection and bronchial carcinoid in a MEN1 family 203
Mitotane enhances doxorubicin cytotoxic activity by inhibiting P-gp in human adrenocortical carcinoma cells 203
Diurnal rhythm of plasma catecholamines in acromegaly 202
MTOR inhibitors response and mTOR pathway in pancreatic neuroendocrine tumors 202
Circadian rhythms of atrial natriuretic peptide, renin, aldosterone, cortisol, blood pressure and heart rate in normal and hypertensive subjects 201
Magmas, a novel over-expressed gene in Pituitary rat cell lines and in human pituitary adenomas: a new pituitary bio marker? 201
DELTA-OPIOID RECEPTOR MODULATION OF THE HYPOTHALAMIC -PITUITARY-ADRENOCORTICAL AXIS 201
Dermorphin decreases plasma LH levels in human: Evidence for a modulatory role of gonadal steroids 201
A new VHL polymorphism in a big family from Ferrara 200
L’iperplasia surrenale congenita e la pubertà precoce 200
Circadian rhythms of atrial natriuretic peptide, blood pressure and heart rate in normal subjects 199
Chromogranin A as a marker of neuroendocrine neoplasia: An Italian Multicenter Study 199
Growth hormone receptor blockade inhibits growth hormone-induced chemoresistance by restoring cytotoxic-induced apoptosis in breast cancer cells independently of estrogen receptor expression. 197
Totale 28.783
Categoria #
all - tutte 303.599
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 20.077
Totale 323.676


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20223.951 0 416 246 180 192 186 164 183 164 338 437 1.445
2022/20234.399 443 303 175 595 687 658 179 383 578 32 214 152
2023/20242.338 200 274 132 62 204 382 71 462 40 28 34 449
2024/20258.348 230 180 625 210 1.067 876 307 351 1.297 985 1.247 973
2025/202630.251 2.330 980 2.087 3.099 3.895 1.660 2.894 1.202 7.887 2.615 998 604
2026/20271.874 917 957 0 0 0 0 0 0 0 0 0 0
Totale 74.742